Risk Factors Associated with Breast Cancer Stage at Diagnosis in Libya: A Multivariate Statistical Application and Analysis
DOI:
https://doi.org/10.65405/evzfah63الكلمات المفتاحية:
Breast cancer; Stage at diagnosis; Risk factors; Logistic regression; Libya; Multivariate analysisالملخص
Background: Breast cancer is the most common malignancy among women in Libya and is frequently diagnosed an advanced stage, adversely affecting prognosis and survival. Evidence on factors independently associated with late-stage presentation in Libya remains limited, particularly from studies employing multivariate statistical methods.
Objectives: This study aimed to identify the demographic, reproductive, behavioral, and biological factors independently associated with advanced-stage breast cancer diagnosis (Stage III) among Libyan women.
Methods: An analytical cross-sectional study was conducted among 220 women with histologically confirmed breast cancer treated at the Al-Riaya Medical Clinic, Tripoli. Data were obtained from structured interviews, medical records, and laboratory databases covering the period 2017–2022. The outcome variable was stage at diagnosis, dichotomized into early stage (Stages I–II) versus advanced stage (Stage III). Multivariate logistic regression analysis was performed to estimate adjusted odds ratios (AORs) and 95% confidence intervals (CIs) for factors associated with Stage III diagnosis.
Results: Of the 220 patients, 44% were diagnosed at Stage III. After adjustment for potential confounders, nulliparity was the strongest predictor of advanced-stage diagnosis (AOR = 6.42, 95% CI: 2.87–14.36; p < 0.001). Symptom-based detection was associated with nearly a fivefold increased likelihood of Stage III disease compared with screening-based diagnosis (AOR = 4.91, 95% CI: 2.24–10.77; p < 0.001). Physical inactivity (AOR = 3.15, 95% CI: 1.45–6.84; p = 0.004), positive family history of cancer (AOR = 2.78, 95% CI: 1.33–5.82; p = 0.007), and vitamin D deficiency (AOR = 2.21, 95% CI: 1.12–4.35; p = 0.022) were also independently associated with advanced-stage diagnosis. Elevated fasting blood glucose showed a positive but non-significant association with Stage III disease.
التنزيلات
المراجع
1. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence
2. Bodalal, Z., Azzuz, R., & Bendardaf, R. (2019). Cancer in Libya: A systematic review. Libyan Journal of Medicine, 14(1), 1632671.
3. Yedjou, C. G., Sims, J. N., Miele, L., Noubissi, F., Lowe, L., Fonseca, D. D., ... & Tchounwou, P. B. (2019). Health and racial disparity in breast cancer. Advances in Experimental Medicine and Biology, 1152, 31–49.
4. Boder, J. M. E., Elmabrouk Abdalla, F. B., Elfageih, M. A., Abusaa, A., Buhmeida, A., & Collan, Y. (2011). Breast cancer patients in Libya: comparison with European and central African patients. Oncology letters, 2(2), 323-330.
5. Naja, F., Nasreddine, L., Awada, S., El Sayed Ahmad, R., & Hwalla, N. (2019). Nutrition in the prevention of breast Cancer: a middle eastern perspective. Frontiers in public health, 7, 316.
6. Azadnajafabad, S., Moghaddam, S. S., Mohammadi, E., Rezaei, N., Rashidi, M. M., Rezaei, N., ... & GBD 2019 NAME Breast Cancer Collaborators. (2023). Burden of breast cancer and attributable risk factors in the North Africa and Middle East region, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Frontiers in Oncology, 13, 1132816.
7. Lacey Jr, J. V., Devesa, S. S., & Brinton, L. A. (2002). Recent trends in breast cancer incidence and mortality. Environmental and molecular mutagenesis, 39(2‐3), 82-88.
8. Desai, K., Baralo, B., Kulkarni, A., Keshava, V. E., Iqbal, S., Ali, H., ... & Thirumaran, R. (2024). Cancer statistics: The United States vs. worldwide.
9. Coughlin, S. S. (2019). Epidemiology of breast cancer in women. Advances in Experimental Medicine and Biology, 1152, 9–29.
10. Sun, Y. S., Zhao, Z., Yang, Z. N., Xu, F., Lu, H. J., Zhu, Z. Y., ... & Zhu, H. P. (2017). Risk factors and preventions of breast cancer. International Journal of Biological Sciences, 13(11), 1387–1397.
11. Hosmer, D. W., Jr., Lemeshow, S., & Sturdivant, R. X. (2013). Applied Logistic Regression (3rd ed.). John Wiley & Sons.
12. El Mistiri, M., Verdecchia, A., Rashid, I., El Sahli, N., El Mangush, M., & Federico, M. (2007). Cancer incidence in eastern Libya: the first report from the Benghazi Cancer Registry, 2003. International Journal of Cancer, 120(2), 392–397.
13. Alam, K., Maity, A., Sinha, S. K., Rizopoulos, D., & Sattar, A. (2021). Joint modeling of longitudinal continuous, longitudinal ordinal, and time-to-event outcomes. Lifetime Data Analysis, 27(1).
14. Mertler, C. A., Vannatta, R. A., & LaVenia, K. N. (2021). Advanced and multivariate statistical methods: Practical application and interpretation. Routledge.
15. Agodirin, O., Aremu, I., Rahman, G., Olatoke, S., Olaogun, J., Akande, H., & Romanoff, A. (2021). Determinants of delayed presentation and advanced-stage diagnosis of breast cancer in Africa: a systematic review and meta-analysis. Asian Pacific journal of cancer prevention: APJCP, 22(4), 1007.
16. Shaukat, N., Jaleel, F., Moosa, F. A., & Qureshi, N. A. (2017). Association between vitamin D deficiency and breast cancer. Pakistan journal of medical sciences, 33(3), 645.
17. Jacobson, S., Dahlqvist, P., Johansson, M., Svensson, J., Billing, O., Sund, M., & Franklin, O. (2021). Hyperglycemia as a risk factor in pancreatic cancer: A nested case-control study using prediagnostic blood glucose levels. Pancreatology, 21(6), 1112-1118.
التنزيلات
منشور
إصدار
القسم
الرخصة
الحقوق الفكرية (c) 2026 مجلة العلوم الشاملة
هذا العمل مرخص بموجب Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
